Use cases show benefits of unlocking data to improve signal and adverse event detection.
Jane Reed, director, life sciences NLP, IQVIA
Advertisement
Articles by Jane Reed, director, life sciences NLP, IQVIA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema
3
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
4
A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
